Penserra Capital Management LLC Eagle Pharmaceuticals, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$45.82 - $56.9 $13,746 - $17,070	-300 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$36.86 - $44.5 $368 - $445	10 Added 3.45%	300 $12,000
Q1 2021 May 13, 2021	SELL	$40.32 - $50.97 $403 - $509	-10 Reduced 3.33%	290 $12,000
Q4 2020 Feb 12, 2021	BUY	$41.72 - $51.34 $7,593 - $9,343	182 Added 154.24%	300 $13,000
Q3 2020 Nov 13, 2020	BUY	$37.02 - $51.28 $4,368 - $6,051	118 New	118 $5,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.